J. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J. Jacob-Nara, Y. Deniz, P. Rowe
{"title":"Dupilumab降低了中度至重度哮喘患者的严重加重率并改善了支气管扩张剂前Fev1,无论其先前的加重史有1、2或3次加重:自由哮喘穿越","authors":"J. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J. Jacob-Nara, Y. Deniz, P. Rowe","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"28 9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse\",\"authors\":\"J. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J. Jacob-Nara, Y. Deniz, P. Rowe\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":222112,\"journal\":{\"name\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"volume\":\"28 9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse